Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells.

Zhang J, Noble NA, Border WA, Owens RT, Huang Y.

Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E810-9. doi: 10.1152/ajpendo.90264.2008. Epub 2008 Jul 29.

2.

Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes.

Doi T, Sakoda T, Akagami T, Naka T, Mori Y, Tsujino T, Masuyama T, Ohyanagi M.

Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1279-H1287. doi: 10.1152/ajpheart.00148.2008. Epub 2008 Jul 25.

3.

Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency.

Brown NJ, Bradford J, Wang Z, Lea W, Ma L, Ma J, Vaughan DE, Fogo AB.

Kidney Int. 2007 Jul;72(1):72-81. Epub 2007 Apr 11.

4.

Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.

Huang Y, Noble NA, Zhang J, Xu C, Border WA.

Kidney Int. 2007 Jul;72(1):45-52. Epub 2007 Mar 28.

5.

Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling?

Fejes-Tóth G, Náray-Fejes-Tóth A.

Endocrinology. 2007 Apr;148(4):1502-10. Epub 2007 Jan 18.

PMID:
17234708
6.

A direct effect of aldosterone on endothelin-1 gene expression in vivo.

Wong S, Brennan FE, Young MJ, Fuller PJ, Cole TJ.

Endocrinology. 2007 Apr;148(4):1511-7. Epub 2007 Jan 11.

PMID:
17218419
7.

Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension.

Opocenský M, Kramer HJ, Bäcker A, Vernerová Z, Eis V, Cervenka L, Certíková Chábová V, Tesar V, Vanecková I.

Hypertension. 2006 Nov;48(5):965-71. Epub 2006 Oct 2.

8.

Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention.

Ge Y, Bagnall A, Stricklett PK, Strait K, Webb DJ, Kotelevtsev Y, Kohan DE.

Am J Physiol Renal Physiol. 2006 Dec;291(6):F1274-80. Epub 2006 Jul 25.

9.

Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.

Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM.

FASEB J. 2006 Jul;20(9):1546-8. Epub 2006 May 23.

10.

Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.

Ma J, Weisberg A, Griffin JP, Vaughan DE, Fogo AB, Brown NJ.

Kidney Int. 2006 Mar;69(6):1064-72.

11.

Mineralocorticoid receptors and cardiovascular damage: it's not just aldosterone.

Funder JW.

Hypertension. 2006 Apr;47(4):634-5. Epub 2006 Feb 27. No abstract available.

12.

Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.

Neves MF, Amiri F, Virdis A, Diep QN, Schiffrin EL; CIHR Multidisciplinary Research Group on Hypertension.

Can J Physiol Pharmacol. 2005 Nov;83(11):999-1006.

PMID:
16391708
13.

Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.

Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C.

Circulation. 2005 Oct 25;112(17):2677-85.

14.

Kidney function in mice lacking aldosterone.

Makhanova N, Lee G, Takahashi N, Sequeira Lopez ML, Gomez RA, Kim HS, Smithies O.

Am J Physiol Renal Physiol. 2006 Jan;290(1):F61-9. Epub 2005 Aug 23.

15.

Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.

Min LJ, Mogi M, Li JM, Iwanami J, Iwai M, Horiuchi M.

Circ Res. 2005 Sep 2;97(5):434-42. Epub 2005 Aug 4.

16.

Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.

Ma J, Albornoz F, Yu C, Byrne DW, Vaughan DE, Brown NJ.

Hypertension. 2005 Aug;46(2):313-20. Epub 2005 Jul 5.

17.

Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.

Fiebeler A, Nussberger J, Shagdarsuren E, Rong S, Hilfenhaus G, Al-Saadi N, Dechend R, Wellner M, Meiners S, Maser-Gluth C, Jeng AY, Webb RL, Luft FC, Muller DN.

Circulation. 2005 Jun 14;111(23):3087-94. Epub 2005 Jun 6.

18.

Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes.

Chun TY, Pratt JH.

Mol Cell Endocrinol. 2005 Jul 15;239(1-2):55-61.

PMID:
15921847
19.

Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system.

Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM.

J Clin Invest. 2005 Apr;115(4):1092-9.

20.

Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice.

Lee G, Makhanova N, Caron K, Lopez ML, Gomez RA, Smithies O, Kim HS.

Endocrinology. 2005 Jun;146(6):2650-6. Epub 2005 Feb 24.

PMID:
15731365
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk